Purchases and Sales Made in Q1 2025 in Day One Biopharmaceuticals, Inc. (DAWN)
This table provides information about the institutional ownership of Day One Biopharmaceuticals, Inc. (DAWN) during Q1 2025. The information is specifically focused on institutions that hold shares of Day One Biopharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2025
Q1 2025
|
State Street Corp
Boston, MA |
SELL
|
- |
-395K- 12.73% |
$3.13M - $5.22M
|
2.71M
$18.4M
|
|
|
May 14, 2025
Q1 2025
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-533K- 31.24% |
$4.23M - $7.04M
|
1.17M
$7.98M
|
|
|
May 15, 2025
Q1 2025
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-586K- 73.32% |
$4.65M - $7.74M
|
213K
$1.45M
|
|
|
May 15, 2025
Q1 2025
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-1.28M- 98.37% |
$10.2M - $17M
|
21.3K
$145K
|
|
|
May 15, 2025
Q1 2025
|
Braidwell LP
Stamford, CT |
SELL
|
- |
-1.34M- 27.43% |
$10.6M - $17.7M
|
3.54M
$24.1M
|